omeprazole has been researched along with Colitis, Microscopic in 3 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Colitis, Microscopic: A condition characterized by chronic watery DIARRHEA of unknown origin, a normal COLONOSCOPY but abnormal histopathology on BIOPSY. This syndrome was first described in 1980 by Read and associates. Subtypes include COLLAGENOUS COLITIS and LYMPHOCYTIC COLITIS. Both have similar clinical symptoms and are distinguishable only by histology.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Some cases of microscopic colitis seem to be associated with omeprazole/esomaprazole exposure." | 7.75 | Microscopic colitis associated with omeprazole and esomeprazole exposure. ( Mattia, AR; Wilcox, GM, 2009) |
| "We systematically searched EMBASE, MEDLINE, Cochrane Database of Systematic Reviews, International Pharmaceutical Abstracts, and Google Scholar using the terms proton-pump inhibitors (omeprazole, lansoprazole, dexlansoprazole, rabeprazole, pantoprazole, or esomeprazole), microscopic colitis, collagenous colitis, and lymphocytic colitis." | 4.95 | Association Between Proton Pump Inhibitors and Microscopic Colitis. ( Badowski, M; Hung, YT; Law, EH; Lee, TA; Sanchez, A; Weems, K, 2017) |
| "Some cases of microscopic colitis seem to be associated with omeprazole/esomaprazole exposure." | 3.75 | Microscopic colitis associated with omeprazole and esomeprazole exposure. ( Mattia, AR; Wilcox, GM, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Law, EH | 1 |
| Badowski, M | 1 |
| Hung, YT | 1 |
| Weems, K | 1 |
| Sanchez, A | 1 |
| Lee, TA | 1 |
| Wilcox, GM | 1 |
| Mattia, AR | 1 |
| Hilmer, SN | 1 |
| Heap, TR | 1 |
| Eckstein, RP | 1 |
| Lauer, CS | 1 |
| Shenfield, GM | 1 |
1 review available for omeprazole and Colitis, Microscopic
| Article | Year |
|---|---|
Association Between Proton Pump Inhibitors and Microscopic Colitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Colitis, Microscopic; Dose-Response Relationship, Drug; Eso | 2017 |
2 other studies available for omeprazole and Colitis, Microscopic
| Article | Year |
|---|---|
Microscopic colitis associated with omeprazole and esomeprazole exposure.
Topics: Aged; Aged, 80 and over; Anti-Ulcer Agents; Colitis, Microscopic; Dose-Response Relationship, Drug; | 2009 |
Microscopic colitis associated with exposure to lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Biopsy; Chronic Disease; Colitis, Collagenous; Coliti | 2006 |